Koichi Ito

Parklands Drive
Southport, QLD 4222, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Journal: Science advances

Published: March 27, 2026

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.

Journal: Cancer research

Published: May 13, 2025

PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.

PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 22, 2024

MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.

MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.

Journal: Cancer research communications

Published: February 20, 2023

PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.

PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.

Journal: Cancer research communications

Published: February 10, 2023

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.

Journal: NPJ breast cancer

Published: September 17, 2016

PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.

PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.

Journal: Breast cancer research : BCR

Published: January 20, 2016

PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.

PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.

Journal: Cancer research

Published: December 17, 2015

PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.

PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.

Journal: Breast cancer research : BCR

Published: February 14, 2015

Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.

Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.

Journal: Bioinformatics (Oxford, England)

Published: October 29, 2014

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.

Journal: Carcinogenesis

Published: June 07, 2013

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

Journal: Cancer metastasis reviews

Published: June 19, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026